Kumar et al. (53) found that AATF promoted progression from non-alcoholic steatohepatitis to hepatocellular carcinoma by enhancing STAT3-mediated expression of monocyte chemoattractant protein 1 (MCP-1). Here, CCL2 is linked to metabolic dysfunction-associated steatohepatitis.